Impact of maintenance rituximab on duration of response in primary central nervous system lymphoma
ConclusionWe are evaluating the effectiveness of maintenance immunotherapy in PCNSL in a prospective multicenter randomized clinical trial.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Clinical Trials | Immunotherapy | Lymphoma | Neurology | PET Scan | Primary CNS Lymphoma | Rituxan